Segment Data (Tables)

12 Months Ended

Dec. 31, 2024

Segment Data

Schedule of reportable segments net revenue and net loss

The Company's reportable segments' net revenues and net loss for the years ended December 31, 2024 and 2023 consisted of the following:

	Year Ended
(in thousands)	December 31, 2024
	Human Health			Animal Health			Total
External revenue	$	11,374		$	315		$	11,689
Less: Segment expenses
Cost of revenue		1,900			55			1,955
Research and development		13,949			2,590			16,539
Sales and marketing		7,381			311			7,692
General and administrative		8,949			9,307			18,256
Interest		113			227			340
Other segment items*		(383	)		8,231			7,848
Segment expenses		31,909			20,721			52,630
Segment net comprehensive loss	$	(20,535	)	$	(20,406	)	$	(40,941	)
Reconciliation of net comprehensive loss
Adjustments and reconciling items**								1,907
Consolidated net comprehensive loss							$	(39,034	)

	Year Ended
(in thousands)	December 31, 2023
	Human Health			Animal Health			Total
External revenue	$	9,588		$	173		$	9,761
Less: Segment expenses
Cost of revenue		1,978			59			2,037
Research and development		15,968			2,577			18,545
Sales and marketing		6,174			300			6,474
General and administrative		9,211			9,681			18,892
Interest		50			6,378			6,428
Other segment items*		(183	)		1,391			1,208
Segment expenses		33,198			20,386			53,584
Segment net comprehensive loss	$	(23,610	)	$	(20,213	)	$	(43,823	)
Reconciliation of net comprehensive loss
Adjustments and reconciling items**								1,953
Consolidated net comprehensive loss							$	(41,870	)

* Other segment items for each reportable segment include:

•Human Health - realized gain/loss on foreign exchange transactions, change in fair value of warrants, gain/loss on debt extinguishment, and share in net income or loss in joint venture.

•Animal Health - realized and unrealized gain/loss on foreign exchange transactions.

** Adjustments and reconciling items include intercompany elimination entries

Schedule of reportable segments assets

The Company’s reportable segments assets consisted of the following:

	December 31,		December 31,
	2024		2023
(in thousands)
Segment assets
Human Health	$	44,117	$	42,289
Animal Health		174,803		153,190
Total	$	218,920	$	195,479

Schedule of reconciliation of segments assets to the consolidated assets

The reconciliation of segments assets to the consolidated assets is as follows:

	December 31,			December 31,
	2024			2023
(in thousands)
Total assets for reportable segments	$	218,920		$	195,479
Less: Investment in subsidiary		(29,232	)		(29,232	)
Less: Intercompany loan		(136,263	)		(115,484	)
Consolidated Totals	$	53,425		$	50,763